The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score and negative profitability metrics raise concerns. Despite strong gross margins and a solid balance sheet with low debt, the company is deeply unprofitable with negative earnings, shrinking revenue, and deteriorating ROE and ROA. Insider selling is aggressive, with $37.91M in sales over the last six months and no buys, while analysts show limited conviction with only a $14.67 target price. The stock trades at elevated valuation multiples despite negative earnings and declining growth, and its 5-year return of -91.4% underscores persistent underperformance.